Atara Biotherapeutics Inc
F:AT2
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Atara Biotherapeutics Inc
F:AT2
|
US |
|
F
|
First Helium Inc
F:2MC
|
CA |
|
I
|
Imperial Brands PLC
OTC:IMBBF
|
UK |
|
M
|
Marathon Oil Corp
XMUN:USS
|
US |
|
S
|
Sompo Holdings Inc
F:ANK
|
JP |
|
F
|
Fifth Third Bancorp
XMUN:FFH
|
US |
|
Tile Shop Holdings Inc
F:2TS0
|
US |
|
D
|
Deutsche Effecten und Wechsel Beteiligungsgesellschaft AG
SWB:EFF
|
DE |
|
L
|
Linde PLC
XHAM:LIN
|
UK |
|
Ciena Corp
NYSE:CIEN
|
US |
|
E
|
Everspin Technologies Inc
F:E5N
|
US |
|
M
|
Marin Software Inc
F:2MAA
|
US |
Wall St Price Targets
AT2 Price Targets Summary
Atara Biotherapeutics Inc
According to Wall Street analysts, the average 1-year price target for AT2 is 11.23 EUR with a low forecast of 8.14 EUR and a high forecast of 15.23 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is AT2's stock price target?
Price Target
11.23
EUR
According to Wall Street analysts, the average 1-year price target for AT2 is 11.23 EUR with a low forecast of 8.14 EUR and a high forecast of 15.23 EUR.
What is the Revenue forecast for Atara Biotherapeutics Inc?
Projected CAGR
-53%
The compound annual growth rate for Revenue over the next 3 years is -53%.
What is the Gross Profit forecast for Atara Biotherapeutics Inc?
Projected CAGR
-51%
The compound annual growth rate for Gross Profit over the next 3 years is -51%.
